openPR Logo
Press release

Peripheral IV Catheter Market is Expected to Progress at a CAGR of 5.8% to Reach US$ 1,865.4 Million by 2034 | Fact.MR Report

05-02-2024 10:00 AM CET | Health & Medicine

Press release from: Fact.MR

Peripheral IV Catheter Market

Peripheral IV Catheter Market

The peripheral IV catheter market in US is predicted to account for 88.6% of the North American market in 2024. It is projected that the US market for peripheral IV catheters would grow by US$ 685 million by 2024. By 2034, the market is expected to reach US$ 1,029 million with a 4.2% compound annual growth rate.

It is projected that the size of the peripheral IV catheter market worldwide would reach US$ 1,058.6 million by 2024. By 2034, the market is expected to grow at a 5.8% CAGR and reach US$ 1,865.4 million.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.factmr.com/connectus/sample?flag=S&rep_id=9654

For public relations (PR) specialists, the peripheral I.V. catheter market offers a distinctive environment with a wealth of chances for strategic communication and brand development. We will examine the dynamics, difficulties, and future growth potential of the Peripheral IV Catheter market in this study, highlighting the critical role public relations plays in influencing attitudes, building connections, and propelling commercial success. The global peripheral I.V. catheter market is expected to rise steadily over the next several years due to a mix of ongoing technology advancements, greater environmental consciousness, and an increasing demand for more efficient operations. It is expected that industry participants would focus on product innovation, strategic partnerships, and global expansion in order to take advantage of the changing market prospects.

๐“๐จ๐ฉ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐๐ซ๐จ๐ฉ๐ž๐ฅ๐ฅ๐ข๐ง๐  ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ž ๐๐ž๐ซ๐ข๐ฉ๐ก๐ž๐ซ๐š๐ฅ ๐ˆ๐• ๐‚๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Peripheral IV catheter sales are benefiting from an aging population and an increase in the prevalence of chronic illnesses.
The market is being driven by a rise in the number of hospitalizations and a notable use of safety-ported short peripheral intravenous catheters.
Peripheral IV catheter use is predicted to be significantly accelerated by the desire to reduce needle-stick injuries and growing healthcare costs.
Peripheral IV catheter use is rising as more people become aware of the benefits of early diagnosis in obtaining blood samples for testing.
Peripheral intravenous catheter use is rising as a result of the rise in chronic illnesses like diabetes, neurological diseases, infectious disorders, etc. that are creating opportunities for players to conduct disease treatment awareness campaigns.
The market is expected to grow as a result of investments made in the development and production of effective peripheral IV catheters, given the growing patient population.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

Key players in the peripheral IV catheter market include Becton, Dickinson, and Company, B. Braun Melsungen AG, Smiths Group plc., Terumo Corporation, Venner Medical, Vygon, Teleflex Incorporated, C. R. Bard, Inc., NIPRO Medical Corporation, and Argon Medical Devices, Inc.

There are both domestic and foreign competitors in this fiercely competitive market. Small and medium-sized businesses are focusing on increasing their market share by investing in technology innovations. Players also use other inorganic and organic tactics, like as alliances, mergers, acquisitions, and the introduction of new products.

Recent Developments in the Peripheral IV Catheter Market

In September 2022, B. Braun Medical Inc. purchased numerous items from Starboard Medical. These devices are used to fasten the Clik-FIX peripheral catheter.

In March 2022, Shockwave Medical Inc. announced that the Shockwave M5+ peripheral IVL catheter-which received FDA certification and the CE Mark-will be made commercially accessible globally.

In July 2022, B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter, which allows for single-time blood control. The most recent invention from B. Braun lowers the risk of needlestick injuries and blood exposure while also improving the safety quotient of IV for medical professionals.

๐†๐ž๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9654

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ž๐ซ๐ข๐ฉ๐ก๐ž๐ซ๐š๐ฅ ๐ˆ๐• ๐‚๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

By Product Type:
Power Injected PICC
Conventional PICC

By Design Type:
Single Lumen
Double Lumen
Multiple Lumen

By End User:
Hospitals
Ambulatory Surgical Centers
Catheterization Labs

By Region:
North America
Europe
Latin America
East Asia
South Asia and Oceania
Middle East and Africa

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

๐€๐›๐จ๐ฎ๐ญ ๐…๐š๐œ๐ญ.๐Œ๐‘

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peripheral IV Catheter Market is Expected to Progress at a CAGR of 5.8% to Reach US$ 1,865.4 Million by 2034 | Fact.MR Report here

News-ID: 3482260 • Views: โ€ฆ

More Releases from Fact.MR

Zein Protein Market Expected to Grow to US$ 3.76 Billion by 2032
05-17-2024 | Food & Beverage
Fact.MR
Zein Protein Market Expected to Grow to US$ 3.76 Billion by 2032
The global zein protein market (Margadh Prรณitรฉin Zein) is currently valued at $2.17 billion and is forecasted to grow to $3.76 billion by the end of 2032, with an expected compound annual growth rate (CAGR) of 5.3% over the next decade. This significant growth trajectory reflects the rising demand for sustainable protein sources and increased awareness of plant-based alternatives. Zein, derived naturally from corn, has emerged as a versatile protein withโ€ฆ
IT Infrastructure Monitoring Market to Grow at 17.3% CAGR, Reaching US$ 21.72 Billion by 2034
IT Infrastructure Monitoring Market to Grow at 17.3% CAGR, Reaching US$ 21.72 Bi โ€ฆ
The global IT Infrastructure Monitoring Market (IT ์ธํ”„๋ผ ๋ชจ๋‹ˆํ„ฐ๋ง ์‹œ์žฅ) is valued at US$ 4.4 billion in 2024 and is expected to grow to US$ 21.72 billion by the conclusion of 2034. IT infrastructure monitoring is evolving into a pivotal domain as organizations increasingly recognize the importance of maintaining the health, performance, and security of their IT ecosystems. IT infrastructure monitoring solutions and services are designed to monitor, analyze, andโ€ฆ
Soy Sauce Powder Market Estimated to Reach US$ 602.8 Million by 2034
05-17-2024 | Food & Beverage
Fact.MR
Soy Sauce Powder Market Estimated to Reach US$ 602.8 Million by 2034
The global Soy Sauce Powder Market (Margadh Pรบdar Salann Soighe) is expected to reach a value of US$ 602.8 million by the end of 2034, with a projected growth rate of 5.5% over the coming decade. Driving this expansion is the shift in consumer tastes towards convenient and adaptable seasoning options. Research conducted by Fact.MR, a leading provider of market research and competitive intelligence, underscores the increasing popularity of soyโ€ฆ
Reduced Fat Meat Market to Grow at 4.6% CAGR, Reaching US$ 15 Billion by 2033
05-17-2024 | Food & Beverage
Fact.MR
Reduced Fat Meat Market to Grow at 4.6% CAGR, Reaching US$ 15 Billion by 2033
The global reduced fat meat market (์ง€๋ฐฉ์ด ์ ์€ ๊ณ ๊ธฐ ์‹œ์žฅ) is projected to reach US$ 15 billion by the end of 2033, with demand expected to grow at a CAGR of 4.6% through 2033. Reducing the total fat content in processed meat is both desirable and feasible. Effective combinations of various fat substitutes can significantly lower levels of saturated fats and caloric content. These improvements lead to the development ofโ€ฆ

All 5 Releases


More Releases for Peripheral

PC Gaming Peripheral Market
PC Gaming Peripheral Market Research study which offers insights of in-depth research on historic and current market size along with the expected future prospects of the market and emerging trends in the market. The PC Gaming Peripheral Market report provides crucial information about the market, including Opinions from Industry experts, and the recent progressions and developments of the PC Gaming Peripheral Market. PC gaming peripheral are external hardware devices such asโ€ฆ
Peripheral Vascular Devices Market Report 2018: Segmentation by Types (Periphera โ€ฆ
Global Peripheral Vascular Devices market research report provides company profile for Abbott Vascular, Bayer Healthcare, Volcano Corporation, Teleflex Medical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentationโ€ฆ
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, โ€ฆ
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations. Request for Sample of This Research Report @ https://bit.ly/2xjOKpC Top Key Player:- Abbott Laboratories Braun Melsungen AG Boston Scientific Corporation R. Brad, Inc. Cardinal Health, Inc. Medtronic plc. Cook Medical, Inc. Teruma Corporation Jude Medical, Inc. The Spectranetics Corporation Volcano Corporation Peripheral vascular disorder (PVD) is a blood circulation disorderโ€ฆ
Peripheral Artery Disease Market By Type (Peripheral Angioplasty Balloons, Perip โ€ฆ
Peripheral artery disease is characterized by plaque built up in the arteries carrying blood from heart to legs, arms, and other limbs. Peripheral artery disease in turn also increases the risk of other cardiovascular disorders such as heart attack, coronary heart disease, stroke, and ischemic attack. Request Sample At: https://www.bigmarketresearch.com/request-sample/1633533 The global peripheral artery disease market generated $3,136 million in 2016, and is projected to reach $4,980 million by 2023, registering aโ€ฆ
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the โ€œPeripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021โ€œThe main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ https://www.mrrse.com/sample/2827 Peripheral intravenous catheter is a sophisticated medical device widely used toโ€ฆ
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline โ€ฆ
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics,โ€ฆ